Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
Boston Scientific, Abbott tout long-term heart occluder data
Boston Scientific and Abbott both put forward studies supporting their respective implants for sealing off the heart’s left atrial appendage.
Conor Hale
Nov 19, 2024 12:00pm
Lilly's lipoprotein-blocking heart drug posts midstage trial win
Nov 19, 2024 9:55am
Ablation before meds shows gains in v-tach after heart attack
Nov 18, 2024 11:45am
FDA clears Omron blood pressure cuff with afib detection
Nov 14, 2024 9:00am
Boston Scientific resumes Farapulse study in first-line afib
Nov 11, 2024 9:35am
TCT: Using TAVR early helps prevent later hospitalizations
Oct 28, 2024 11:22am
